This inventor holds 1 USPTO granted patent. Top assignee: Takeda Pharmaceutical Company Limited. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Yongquan Lai: Innovator in Functional C1 Esterase Inhibitor Quantitation
Introduction
Yongquan Lai is a notable inventor based in Lexington, MA (US). He has made significant contributions to the field of biochemistry, particularly in the quantitation of functional C1 esterase inhibitor (fC1-INH). His innovative methods have the potential to enhance diagnostic processes in medical science.
Latest Patents
Yongquan Lai holds 1 patent for his work titled "Methods for quantitation of functional C1 esterase inhibitor (FC1-INH)." This patent outlines methods for quantifying fC1-INH from dried blood spots. The process involves spotting and drying a blood sample on a support member, extracting protein from the dried blood sample, and measuring the level of fC1-INH in the extracted proteins.
Career Highlights
Yongquan Lai is currently employed at Takeda Pharmaceutical Company Limited, where he continues to advance his research and development efforts. His work is crucial in the pharmaceutical industry, particularly in the development of therapies related to blood disorders.
Collaborations
Yongquan has collaborated with esteemed colleagues such as Guodong Zhang and Zhiwei Zhou. Their combined expertise contributes to the innovative research and development at Takeda Pharmaceutical Company Limited.
Conclusion
Yongquan Lai's contributions to the field of functional C1 esterase inhibitor quantitation exemplify the impact of innovative research in medicine. His work not only advances scientific understanding but also holds promise for improving patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile